Azopt (Alcon Laboratories, Inc.)
Welcome to the PulseAid listing for the Azopt drug offered from Alcon Laboratories, Inc.. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alcon Laboratories, Inc. |
NON-PROPRIETARY NAME: | brinzolamide |
SUBSTANCE NAME: | BRINZOLAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SUSPENSION/ DROPS |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1998-04-30 |
END MARKETING DATE: | 0000-00-00 |
Azopt HUMAN PRESCRIPTION DRUG Details:
Item Description | Azopt from Alcon Laboratories, Inc. |
LABELER NAME: | Alcon Laboratories, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 1998-04-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0065-0275_6a15ac34-058c-447d-384e-142206d08d28 |
PRODUCT NDC: | 0065-0275 |
APPLICATION NUMBER: | NDA020816 |
Other BRINZOLAMIDE Pharmaceutical Manufacturers / Labelers: